过去一年中添加的文章,按日期排序

Abstract PO3-08-03: Comparing prognosis for BRCA1, BRCA2 and non-BRCA breast cancer

PA Meireles, C Bexiga, S Fragoso, S Santos, T Duarte… - Cancer Research, 2024 - AACR
94 天前 - familial BC cases, are highly penetrant and are associated with Hereditary
Breast/Ovarian CancerBRCA1 and BRCA2 associated BC have distinct clinicopathological …

FDA Grants Marketing Authorization to First DNA Test to Assess Multiple Cancer Predispositions.

L Fischer - Oncology Nursing News, 2023 - go.gale.com
305 天前 - … Some of the most clinically significant genes that can be identified through the
test include: * BRCA1 and BRCA2 (associated with hereditary breast and ovarian cancer

Updates in the Pathology and Therapy of BRCA Germline–Associated Breast Cancer with a Focus on HER2 Amplification

DW Kim, CX Cruz Pico, E Forester, A Belsare… - Current Breast Cancer …, 2023 - Springer
359 天前 - … of the breast cancer type 1 or 2 susceptibility genes (… majority of hereditary breast
and ovarian cancer syndromes (… % in BRCA1 and 13% in BRCA2-associated breast cancers. …